Marc Blaustein

Insider Reports History

Entity
Individual
Location
C/O Finch Therapeutics Group, Inc., 200 Inner Belt Road, Suite 400, Somerville, MA
Signature
/s/ Sydney Gaylin, Attorney in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Marc Blaustein:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Finch Therapeutics Group, Inc. Chief Operating Officer Common Stock 28K $102K $3.64 Feb 21, 2023 Direct

Insider Reports Filed by Marc Blaustein

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FNCH Finch Therapeutics Group, Inc. Feb 21, 2023 1 -$1.76K 4 Feb 23, 2023 Chief Operating Officer
FNCH Finch Therapeutics Group, Inc. Oct 21, 2022 1 -$5.05K 4 Oct 25, 2022 Chief Operating Officer
FNCH Finch Therapeutics Group, Inc. Jun 13, 2022 1 $0 4 Jun 15, 2022 Chief Operating Officer
FNCH Finch Therapeutics Group, Inc. Feb 25, 2022 1 $0 4 Feb 28, 2022 Chief Operating Officer
FNCH Finch Therapeutics Group, Inc. Sep 8, 2021 1 $0 4 Sep 10, 2021 Chief Operating Officer
FNCH Finch Therapeutics Group, Inc. Sep 8, 2021 0 $0 3 Sep 10, 2021 Chief Operating Officer